Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stage IV Small Cell Lung Carcinoma”

1,437 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,437 results

Testing effectiveness (Phase 2)Study completedNCT00002475
What this trial is testing

Cyclophosphamide Plus Vaccine Therapy in Treating Patients With Advanced Cancer

Who this might be right for
Breast CancerColorectal CancerKidney Cancer+3 more
St. Vincent Medical Center - Los Angeles 40
Large-scale testing (Phase 3)Not Yet RecruitingNCT07365319
What this trial is testing

A Safety and Efficacy Study of EIK1001 in Combination With Pembrolizumab and Chemotherapy in Participants With Stage 4 Non-Small Cell Lung Cancer.

Who this might be right for
Non Small Cell Lung Cancer (Squamous or Non Squamous)Stage 4 NSCLC
Eikon Therapeutics 750
Testing effectiveness (Phase 2)Study completedNCT00003565
What this trial is testing

Docetaxel in Treating Patients With Solid Tumors

Who this might be right for
Bladder CancerBreast CancerHead and Neck Cancer+2 more
Alliance for Clinical Trials in Oncology 109
Early research (Phase 1)Study completedNCT00161187
What this trial is testing

Irradiated Donor Lymphocyte Infusion in Treating Patients With Relapsed or Refractory Hematologic Cancer or Solid Tumor

Who this might be right for
Cancer
University of Medicine and Dentistry of New Jersey 37
Testing effectiveness (Phase 2)Study completedNCT00327535
What this trial is testing

Mircera in Anemic Patients With Non-Small Cell Lung Cancer Receiving First Line Chemotherapy.

Who this might be right for
Anemia
Hoffmann-La Roche 153
Large-scale testing (Phase 3)Looking for participantsNCT06096844
What this trial is testing

Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial

Who this might be right for
Advanced Lung Non-Small Cell CarcinomaStage IIIB Lung Cancer AJCC v8Stage IIIC Lung Cancer AJCC v8+1 more
National Cancer Institute (NCI) 304
Testing effectiveness (Phase 2)Study completedNCT02392507
What this trial is testing

Nab-Paclitaxel and Carboplatin Plus Necitumumab (LY3012211) in Participants With Stage IV Squamous NSCLC

Who this might be right for
Carcinoma, Non-Small Cell Lung Cancer (NSCLC)
Eli Lilly and Company 54
Testing effectiveness (Phase 2)Study completedNCT00283244
What this trial is testing

Ph II Gemcitabine, Erlotinib, and Gemcitabine With Erlotinib/Elderly Patients W/ IIIB/IV NSCLC

Who this might be right for
Lung Cancer
UNC Lineberger Comprehensive Cancer Center 147
Testing effectiveness (Phase 2)UnknownNCT03048500
What this trial is testing

Nivolumab and Metformin Hydrochloride in Treating Patients With Stage III-IV Non-small Cell Lung Cancer That Cannot Be Removed by Surgery

Who this might be right for
Recurrent Non-Small Cell Lung CarcinomaStage III Non-Small Cell Lung CancerStage IIIA Non-Small Cell Lung Cancer+2 more
Northwestern University 17
Testing effectiveness (Phase 2)Study completedNCT00660816
What this trial is testing

Pemetrexed or Docetaxel With or Without Erlotinib in Stage IIIB or Stage IV Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Case Comprehensive Cancer Center 46
Early research (Phase 1)Ended earlyNCT01212887
What this trial is testing

Treated Blood Cells, Cyclophosphamide, Fludarabine Phosphate, and Aldesleukin in Treating Patients With Cancer

Who this might be right for
Breast CancerColorectal CancerGastric Cancer+4 more
Cancer Research UK 14
Large-scale testing (Phase 3)Ended earlyNCT00738387
What this trial is testing

ASA404 or Placebo in Combination With Docetaxel in Second-line Treatment for (Stage IIIb/IV) Non-small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung Cancer
Novartis Pharmaceuticals 900
Not applicableLooking for participantsNCT04723095
What this trial is testing

Establishing a Tumor Registry for Patients With Neuroendocrine Carcinoma of the Cervix

Who this might be right for
Cervical Large Cell Neuroendocrine CarcinomaCervical Neuroendocrine CarcinomaCervical Small Cell Carcinoma+19 more
M.D. Anderson Cancer Center 750
Not applicableUnknownNCT03258671
What this trial is testing

IMRT and Timing in Combination With EGFRTKI for Stage IV Non-small-cell Lung Cancer

Who this might be right for
Non-Small Cell Lung CancerNonsmall Cell Lung CancerCarcinoma, Non-Small-Cell Lung
LuBing 160
Testing effectiveness (Phase 2)Active Not RecruitingNCT03225664
What this trial is testing

Trametinib and Pembrolizumab in Treating Patients With Recurrent Non-small Cell Lung Cancer That Is Metastatic, Unresectable, or Locally Advanced

Who this might be right for
Metastatic Lung Non-Small Cell CarcinomaRecurrent Lung Non-Small Cell CarcinomaStage III Lung Cancer AJCC v8+7 more
M.D. Anderson Cancer Center 37
Testing effectiveness (Phase 2)Looking for participantsNCT04616209
What this trial is testing

Allogeneic PB103 (NK Cells) Therapy in Non-small Cell Lung Cancer (NSCLC) Patients

Who this might be right for
Non-small Cell Lung Cancer
Precision Biotech Taiwan Corp. 24
Testing effectiveness (Phase 2)Active Not RecruitingNCT05012254
What this trial is testing

Nivolumab and Ipilimumab Plus Chemotherapy for Patients With Stage IV Lung Cancer With Brain Metastases

Who this might be right for
Non Small Cell Lung CancerBrain Metastases, AdultLung Cancer
Fundación GECP 71
Testing effectiveness (Phase 2)WithdrawnNCT02495636
What this trial is testing

Phase 2 Study of MPDL3280A Combined With CDX-1401 in NY-ESO 1 (+) IIIB, IV or Recurrent Non-Small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung Cancer
Yale University
Testing effectiveness (Phase 2)Study completedNCT00003072
What this trial is testing

Combination Chemotherapy in Treating Patients With Metastatic Ovarian Cancer or Non-small Cell Lung Cancer

Who this might be right for
Lung CancerNeurotoxicityOvarian Cancer
University of California, San Francisco 80
Testing effectiveness (Phase 2)UnknownNCT03830411
What this trial is testing

Sintilimab Compared With Docetaxel or Pemetrexed as Second-line Treatment for Patients With Stage IV Nonsquamous Non-small Cell Lung Cancer After Failure With Platinum-Containing Chemotherapy

Who this might be right for
Nonsquamous Non-Small Cell Lung Cancer
Xin-Hua Xu 76
Load More Results